Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eletone
- Development stage
- Unknown
- Lead developer
- Ferndale Laboratories
- Administration
- Topical
01
Overview
Eletone is a prescription-only, non-steroidal barrier cream indicated for the management and relief of burning, itching, and pain associated with various types of dermatoses, including atopic dermatitis and allergic contact dermatitis. It functions by providing a physical barrier that protects the skin from external irritants and helps maintain a moist environment conducive to healing. Originally developed by Ferndale Healthcare and acquired by Mission Pharmacal in 2014, Eletone is designed to restore skin barrier function without the use of corticosteroids, making it a strategic asset in pediatric and dermatological care.
- Brand names
- Eletone
- Other names
- Eletone Cream
Beyond the preview
Go deeper on Eletone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eletone.